Michael Sanders

TL;DR: It is concluded that RF lesioning in the sphenopalatine ganglion via the infrazygomatic approach may be performed in patients suffering from cluster headache that does not respond to pharmacological therapy.

TL;DR: Use of primary SRS alone in this setting is associated with an increasingly significant risk of BTR with increasing survival time, and the majority of such recurrences are symptomatic and associated with a neurologic deficit, a finding not analyzed in recently reported experiences withholding whole brain radiation therapy as part of the primary treatment of brain metastasis.

TL;DR: The polymer gel dosimeter has been shown to be a valuable device for displaying three-dimensional dose distributions and can be compared easily with calculated dose distributions, to validate a treatment planning system.

TL;DR: The results indicated that the sensitivity of the improved film was about 40% greater than that of MD-55 film, and the response of theimproved film was found to be uniform within 4% only in one direction of the film.

TL;DR: First, optimal control of brain metastasis < or =2 cm was seen with 20-Gy SRS combined with planned WBRT, and second, SRS doses >20 Gy resulted in no obvious improvement in local control and appeared to be associated with a greater rate of complications.